In short, although HGF-secreting MSCs in the MSCs group contributed significantly to the recovery of local ANFH lesion, fibrin glue-compounded transgenic MSCs could maintain longer survival period of MSCs and result in prolonged HGF secretion time which provide more sustainable and effective therapeutic effects in treatment of ANFH. The gene discussed is HGF; the disease is familial avascular necrosis of femoral head.